These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 28935443)

  • 1. Complex formation with protamine prolongs the thrombin-inhibiting effect of DNA aptamer in vivo.
    Spiridonova VA; Novikova TM; Nikulina DM; Shishkina TA; Golubkina EV; Dyukareva OS; Trizno NN
    Biochimie; 2018 Feb; 145():158-162. PubMed ID: 28935443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of a new DNA aptamer, direct inhibitor of thrombin.
    Mazurov AV; Titaeva EV; Khaspekova SG; Storojilova AN; Spiridonova VA; Kopylov AM; Dobrovolsky AB
    Bull Exp Biol Med; 2011 Feb; 150(4):422-5. PubMed ID: 22268033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A high affinity, antidote-controllable prothrombin and thrombin-binding RNA aptamer inhibits thrombin generation and thrombin activity.
    Bompiani KM; Monroe DM; Church FC; Sullenger BA
    J Thromb Haemost; 2012 May; 10(5):870-80. PubMed ID: 22385910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA Aptamers to Thrombin Exosite I. Structure-Function Relationships and Antithrombotic Effects.
    Spiridonova VA; Novikova TM; Sizov VA; Shashkovskaya VS; Titaeva EV; Dobrovolsky AB; Zharikova EB; Mazurov AV
    Biochemistry (Mosc); 2019 Dec; 84(12):1521-1528. PubMed ID: 31870256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of protamine sulfate with thrombin.
    Cobel-Geard RJ; Hassouna HI
    Am J Hematol; 1983 May; 14(3):227-33. PubMed ID: 6846326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HD1, a thrombin- and prothrombin-binding DNA aptamer, inhibits thrombin generation by attenuating prothrombin activation and thrombin feedback reactions.
    Kretz CA; Cuddy KK; Stafford AR; Fredenburgh JC; Roberts R; Weitz JI
    Thromb Haemost; 2010 Jan; 103(1):83-93. PubMed ID: 20062917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface plasmon resonance spectroscopy study of interfacial binding of thrombin to antithrombin DNA aptamers.
    Tang Q; Su X; Loh KP
    J Colloid Interface Sci; 2007 Nov; 315(1):99-106. PubMed ID: 17689549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Micellar Thrombin-Binding Aptamers: Reversible Nanoscale Anticoagulants.
    Roloff A; Carlini AS; Callmann CE; Gianneschi NC
    J Am Chem Soc; 2017 Nov; 139(46):16442-16445. PubMed ID: 29135251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of a Bivalent Thrombin Binding Aptamer and Its Antidote with Improved Properties.
    Hughes QW; Le BT; Gilmore G; Baker RI; Veedu RN
    Molecules; 2017 Oct; 22(10):. PubMed ID: 29048375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel antidote-controlled anticoagulant reduces thrombin generation and inflammation and improves cardiac function in cardiopulmonary bypass surgery.
    Nimjee SM; Keys JR; Pitoc GA; Quick G; Rusconi CP; Sullenger BA
    Mol Ther; 2006 Sep; 14(3):408-15. PubMed ID: 16765093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a novel sensing probe using DNA aptamer inhibiting enzymatic activity.
    Ikebukuro K; Yoshida W; Sode K
    Nucleic Acids Symp Ser (Oxf); 2005; (49):83-4. PubMed ID: 17150644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversible regulation of aptamer activity with effector-responsive hairpin oligonucleotides.
    Li N
    J Lab Autom; 2013 Feb; 18(1):77-84. PubMed ID: 22651934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved RE31 Analogues Containing Modified Nucleic Acid Monomers: Thermodynamic, Structural, and Biological Effects.
    Kotkowiak W; Wengel J; Scotton CJ; Pasternak A
    J Med Chem; 2019 Mar; 62(5):2499-2507. PubMed ID: 30735377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative in vitro study of anticoagulant activity of RA36 DNA aptamer in human, rabbit, and rat blood plasma].
    Savchik EIu; Kalinina TB; Drozd NN; Makarov VA; Zav'ialova EG; Lapsheva EN; Babiĭ AV; Mudrik NN; Pavlova GV; Golovin AV; Kopylov AM
    Eksp Klin Farmakol; 2012; 75(11):13-8. PubMed ID: 23323327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro evaluation of anti-factor IXa aptamer on thrombin generation, clotting time, and viscoelastometry.
    Tanaka KA; Szlam F; Rusconi CP; Levy JH
    Thromb Haemost; 2009 May; 101(5):827-33. PubMed ID: 19404534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a novel DNA sensing system using DNA aptamer inhibited enzymatic activity 1.
    Ikebukuro K; Yoshida W; Sode K
    Nucleic Acids Symp Ser (Oxf); 2004; (48):231-2. PubMed ID: 17150563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4-thio-deoxyuridylate-modified thrombin aptamer and its inhibitory effect on fibrin clot formation, platelet aggregation and thrombus growth on subendothelial matrix.
    Mendelboum Raviv S; Horváth A; Aradi J; Bagoly Z; Fazakas F; Batta Z; Muszbek L; Hársfalvi J
    J Thromb Haemost; 2008 Oct; 6(10):1764-71. PubMed ID: 18665927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a novel DNA sensing system using DNA aptamer that inhibits enzymatic activity 2.
    Ikebukuro K; Yoshida W; Noma T; Sode K
    Nucleic Acids Symp Ser (Oxf); 2004; (48):309-10. PubMed ID: 17150602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased anticoagulant activity of thrombin-binding DNA aptamers by nanoscale organization on DNA nanostructures.
    Rangnekar A; Zhang AM; Li SS; Bompiani KM; Hansen MN; Gothelf KV; Sullenger BA; LaBean TH
    Nanomedicine; 2012 Jul; 8(5):673-81. PubMed ID: 21889476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulant characteristics of HD1-22, a bivalent aptamer that specifically inhibits thrombin and prothrombinase.
    Müller J; Freitag D; Mayer G; Pötzsch B
    J Thromb Haemost; 2008 Dec; 6(12):2105-12. PubMed ID: 18826387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.